Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Nasonex® to be removed from Select Drug Program® Formulary

December 1, 2014

[

Effective January 1, 2015, Nasonex® will be removed from the Select Drug Program Formulary. This change will move the drug from tier 2 (formulary level of cost-sharing) to tier 3 (non-formulary level of cost-sharing). Additionally, Nasonex® will require prior authorization. Generic intranasal corticosteroids, such as fluticasone, flunisolide and budesonide, are available at tier 1, the lowest level of cost-sharing, with no requirement for prior authorization. While there are over-the-counter (OTC) products available, they are not covered under the pharmacy benefit.

Please discuss the generic intranasal corticosteroid alternatives and the proper use of prescription and OTC products with your patients to determine the most appropriate plan of action.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.